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Abstract
Periodontitis is a common human chronic inflammatory disease that results in the destruction of the tooth attachment
apparatus and tooth loss. Although infections with periopathogenic bacteria such as Porphyromonas gingivalis (P. gingivalis)
and Fusobacterium nucleatum (F. nucleatum) are essential for inducing periodontitis, the nature and magnitude of the
disease is determined by the host’s immune response. Here, we investigate the role played by the NK killer receptor NKp46
(NCR1 in mice), in the pathogenesis of periodontitis. Using an oral infection periodontitis model we demonstrate that
following F. nucleatum infection no alveolar bone loss is observed in mice deficient for NCR1 expression, whereas around
20% bone loss is observed in wild type mice and in mice infected with P. gingivalis. By using subcutaneous chambers
inoculated with F. nucleatum we demonstrate that immune cells, including NK cells, rapidly accumulate in the chambers and
that this leads to a fast and transient, NCR1-dependant TNF-a secretion. We further show that both the mouse NCR1 and the
human NKp46 bind directly to F. nucleatum and we demonstrate that this binding is sensitive to heat, to proteinase K and to
pronase treatments. Finally, we show in vitro that the interaction of NK cells with F. nucleatum leads to an NCR1-dependent
secretion of TNF-a. Thus, the present study provides the first evidence that NCR1 and NKp46 directly recognize a
periodontal pathogen and that this interaction influences the outcome of F. nucleatum-mediated periodontitis.
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Introduction
Chronic inflammatory periodontal disease is initiated by several
bacterial pathogens. The infection leads to an inflammatory
process which results in the destruction of the dental attachment
apparatus associated with tooth loss in adults over the age of 35. As
such, it affects about one-half of working American adults [1].
The health risks of periodontal disease are not limited to the
dentition. Increasing evidence suggests that periodontitis may be
an aggravating factor which significantly enhances the risk for
developing bacterial endocarditis, aspiration pneumonia, osteo-
myelitis in children, preterm low birth weight, coronary heart
disease, cerebral infarction, atherosclerosis and diabetes mellitus
[2–7]. Recently, several reports also showed a strong association
between rheumatoid arthritis and periodontitis [8]. This correla-
tion may have a causative nature due to protein citrullination by P.
gingivalis [9]. Nevertheless, although the presence of a periodontal
pathogen is prerequisite for periodontitis development, the
progression of the disease is dependent on the host innate and
adaptive immune responses [10].
NK cells, which are part of the innate immunity, are able to
directly kill tumor and virus-infected cells and are also a source for
immune mediating cytokines [11]. The function of NK cells is
controlled by both inhibitory and activating receptors [12,13].
When the activity of NK cells is balanced towards activation, it
leads to enhanced killing, enhanced production of cytokines, or
both [14,15]. The activating NK receptors includes: the NKp44,
NKp30 and NKp46 receptors collectively known as NCR (Natural
Cytotoxicity Receptors), 2B4, NKp80, CD16 and NKG2D. The
ligands recognized by these receptors are either induced by stress
(ligands for NKG2D, see [11,16]), are viral proteins such as
hemagglutinin (ligands for NKp44 and NKp46, see [17,18]) and
pp65 (ligands for NKp30, see [19]), are self-ligands [20] or are
unknown tumor ligands. Among the NK activating receptors, the
NKp46 receptor (NCR1 in mice) is the only receptor that is
expressed specifically by NK cells of both human and mice
PLoS Pathogens | www.plospathogens.org 1 March 2012 | Volume 8 | Issue 3 | e1002601[11,21]. The direct in vivo role played by NKp46 in the killing of
some tumors, influenza virus-infected cells and even self-beta cells
was demonstrated using mice in which the NKp46 receptor is
‘‘knocked-out’’ (Ncr1
gfp/gfp mice, see [20,21]). Importantly, with
regard to the current research, NKp46 is not only involved in NK
cytotoxicity, but also in production of cytokines [15,22].
The activity of NK cells in periodontitis has been scarcely
studied and to the best of our knowledge, the involvement of the
NK killer receptors in the disease was not investigated at all. This
is quite surprising since impaired NK cells cytotoxicity has been
described in several genetic and acquired conditions associated
with periodontal involvement [23–26]. It has also been well
documented that the local inflammatory response to periodontal
bacteria is maintained and amplified by the production of pro-
inflammatory cytokines, including TNF-a, IFN-c and IL1-b
[10,27,28], the former two being produced by NK cells [29,30].
In addition, a role for antimicrobial peptides, which are also
secreted by NK cells [31,32], has been also implicated in the
pathogenesis of periodontal disease [33,34].
The present study aimed to address the role of NK cells in
general, and of their activating receptor NKp46, in particular, in
the pathogenesis of periodontal disease. We demonstrate that F.
nucleatum, a major etiologic bacteria involved in the pathogenesis of
periodontal disease, is directly recognized by the mouse NCR1
and by the human NKp46 receptors and we show that the
interaction between NCR1 and F. nucleatum probably leads to a
rapid and specific secretion of TNF-a, resulting in alveolar bone
loss. Collectively our results demonstrate that NK cells through
their killing receptor NKp46 play a critical role in the pathogenesis
of F. nucleatum-mediated periodontal disease.
Results
NCR1 controls the F. nucleatum-mediated alveolar bone
loss
The important clinical outcome of oral inflammation that is
induced by periodontal pathogens is the degradation of gingival
connective tissue and the loss of alveolar bone which supports the
teeth. Although the mechanisms underlying the inflammatory
process which leads to the destruction of the supporting apparatus
are not fully understood, TNF-a was demonstrated to be critical
for disease induction [35–37]. Because TNF-a is secreted by NK
cells and because NKp46 triggering can lead to TNF-a secretion
we wondered whether NCR1 is involved in alveolar bone loss. To
investigate this, we induced experimental periodontitis in wild type
C57BL/6 mice and in the NCR1 knockout mice (Ncr1
gfp/gfp,
C57BL/6 background) that were generated in our laboratory by
replacing the Ncr1 gene with GFP [21]. Mice were orally infected
with F. nucleatum and with P. gingivalis and the levels of alveolar
bone loss were quantified by micro-CT ([38,39], Figure 1A).
Around 20% bone loss was observed in the Ncr1
+/+ wild type
C57BL mice infected with F. nucleatum, compared to the Ncr1
gfp/gfp
KO mice in which bone loss was not detected at all (Figure 1B).
Infection with P. gingivalis also resulted in alveolar bone loss which
was similar to that of F. nucleatum. However, this bone loss was
observed in both wild type and Ncr1
gfp/gfp KO mice and no
statistically significant differences were observed between the mice
(Figure 1B).
Infiltration of immune cells into infected subcutaneous
chambers
The experimental periodontis model is not suitable for
investigating NK cell activities because of technical problems,
tissue limitations and due to ethical restrictions. Therefore, to
further investigate the role played by NK cells in F. nucleatum
infection we used subcutaneous chambers which were implanted
into mice in the dorsolumbar region [40,41]. This model allows
the direct quantification of inflammatory cells and mediators in the
inflammatory exudates following bacterial challenge [40].
Subcutaneous chambers were implanted in Ncr1
gfp/gfp KO mice.
Two weeks after the implantation, when the outer incision healed
completely and the chambers became encapsulated by a thin
vascularized layer of fibrous connective tissue, the chambers were
inoculated with the two periodontal pathogens F. nucleatum, P.
gingivalis, or with Escherichia coli (E. coli, used as a non–periodontal
gram negative bacterial control).
In agreement with previous reports [41,42], a rapid and massive
leukocyte infiltrate was observed in the chamber exudates
following bacterial inoculation (Figure 2). NK cells (GFP-positive)
were detected in the chambers as early as 2 hours post inoculation
(Figure 2, left quadrates). The percentages and the numbers of NK
cells increased at 24 hours following the inoculation, except for the
E. coli-inoculated group (Figure 2).
To further characterize the NK population that accumulated in
the chambers following bacteria inoculation, we stained the cell
content of the chambers with antibodies directed against NK cell
receptors; NKG2D, DX5 and NK1.1. As can be seen in Figure 2,
all of the GFP labeled NK cells were NK1.1 positive and CD3
negative (not shown) and most of them, at 2 hours post infection,
were DX5 and NKG2D positive. A reduction in the expression of
DX5 and of NKG2D on NK cells was observed twenty-four hours
following the inoculation of F. nucleatum and P. gingivalis (Figure 2).
Notably, NK cells (GFP positive) were the minor immune cell
population present in the chambers (Figure 2) as most of cells that
express NK cell markers such as NKG2D, DX5 and NK1.1, were
actually GFP negative, (Figure 2).
The presence or absence of NKp46 did not affect bacterial loads
in the chambers (data not shown and figures below). Furthermore,
both P. gingivalis and F. nucleatum bacteria were detected in the
chambers 2 hours following inoculation and little or no bacteria
was detected at 24 hours following inoculation (Figure 3 depicting
the Ncr1
gfp/gfp mice, and data not shown). In contrast, the E. coli
load was significantly increased during the tested period (Figure 3).
Thus, we conclude that the vast majority of lymphocytes in the
chambers are not NK cells, that the in vivo accumulation of
lymphocytes in the chambers is rapid, that low percentages and
numbers of NK cells are observed in the chambers and that the
Author Summary
Periodontal disease is a common bacterial-induced inflam-
matory process in which F. nucleatum and P. gingivalis
infections lead to the destruction of the teeth supporting
attachment apparatus. Previous reports demonstrated that
immune cells aggravate the severity of the disease.
However, whether NK cells in general and NKp46 (a major
killer receptor expressed by NK cells) in particular, play a
protective or destructive role in this disease is unknown.
Using mice deficient in NCR1 (the mouse orthlogue of
NKp46), we demonstrate that oral infection of mice with F.
nucleatum, but not with P. gingivalis results in an NCR1-
dependent alveolar bone loss. In addition, we show that F.
nucleatum is recognized by NCR1 and NKp46 directly and
that this recognition leads to the secretion of TNF-a,a
central cytokine critically involved in the pathogenesis of
periodontal destruction. Collectively, we show that NCR1
and NKp46 play a critical role in the pathogenesis of F.
nucleatum-mediated periodontitis.
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tantly with the disappearance of the two periodontal pathogens.
F. nucleatum inoculation leads to an NCR1-dependent
accumulation of TNF-a
NKp46/NCR1 is an activating receptor involved in the killing
of virus-infected, tumor cells and self-cells [20,21] and in the
secretion of IFN-c and of TNF-a in response to various
stimulations [29]. We therefore next examined whether the
absence of NCR1 will affect the cytokines milieu that is present
in the chambers exudates. The exudates of all chambers were
collected at time 0 (before inoculation), at 2 and at 24 hours post
inoculation and IFN-c and TNF-a levels were measured. Under
the tested experimental conditions, the levels of IFN-c in the
chambers could hardly be detected (data not shown). In contrast, a
significant and rapid increase in the levels of TNF-a was observed
in the Ncr1
+/+ WT mice, 2 hours following the challenge with F.
nucleatum (Figure 4). This elevation was NCR1 dependent, since
the levels of TNF-a in the F. nucleatum-challenged Ncr1
gfp/gfp KO
mice were only modestly increased (Figure 4).
In agreement with the above results, twenty four hours post
inoculation of F. nucleatum, concomitantly with the disappearance
of the bacteria (Figure 3), the TNF-a amounts in the exudates
dropped to minimal in both the Ncr1
+/+ WT and the Ncr1
gfp/gfp
KO mice (Figure 4).
Interestingly, P. gingivalis did not induce TNF-a secretion.
Increase in TNF-a secretion was also observed following E. coli
inoculation however this increase was NCR1 independent and was
less pronounced as compared with F. nucleatum-mediated secretion
(Figure 4). Furthermore, in agreement with the presence of E. coli
in the chambers during the entire tested time period (Figure 3), the
increased TNF-a secretion observed following E. coli inoculation
did not significantly changed between 2 hours and 24 hours.
We also tried performing an intracellular staining for TNF-a in
the NK cells isolated from the chambers. However, these NK cells
did not survive the 5 hours Brefeldin A treatment, and without this
treatment we could not detect TNF-a.
Immune cell accumulation in the infected chambers in
the presence and in the absence of NCR1
To better characterize the immune cell populations present in
the inflamed chambers and to investigate whether in the absence
of NCR1 the percentage and the number of immune cells present
in the chambers will be altered, we implanted chambers in the
NCR1 knockout, Ncr1
gfp/gfp mice (KO) and in the heterozygous,
Ncr1
+/gfp mice (HET, we used the Ncr1
+/gfp mice because the
Figure 1. NCR1-dependent bone loss. (A) Mesio-distal view on a random section. Red, yellow, gray and green represent the enamel, dentin, bone
and the residual bone area above the reference line, respectively. (B) Ncr1
+/+ (WT) and Ncr1
gfp/gfp (KO) mice (n=8 in each group) were challenged
orally three times at 2-day intervals with inoculums of F. nucleatum and of P. gingivalis (2610
8 CFU in 0.2 ml of PBS and 2% carboxymethylcellulose).
Six weeks later, the jaws were harvested and the residual alveolar bone volume (mm
3610
23) was measured. Error bars represent SD. Data represent
percentage of bone loss 6 SD and are average of two independent experiments. ** p,0.01. The difference in bone loss between the KO and the WT
mice following P. gingivalis inoculation was not statistically significant, p,0.09.
doi:10.1371/journal.ppat.1002601.g001
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additional advantage as all NK and NK-like cells are GFP-
positive, [21]). Since the NCR1 effect was observed 2 hours
following F. nucleatum injection (see above figures) we inoculated
the HET and KO mice with F. nucleatum and assayed for the
presence of various immune cells two hours post infection.
Surprisingly, as can be seen in Figure 5, more lymphocytes had
accumulated in the F. nucleatum infected chambers in the absence
of NCR1 (the reasons for this are currently unknown). The T cell
numbers (CD3+) were, in general, twice as large as the NK cell
numbers and most of these T cells were helper CD4+ cells
(Figure 5A). Macrophages (detected by F4/80+ staining) and DC
(detected by CD11c staining) were also present in the chambers
more or less at equal levels, irrespectively of whether NCR1 is
present or is absent (Figure 5B).
NCR1 and NKp46 directly interact with F. nucleatum
To test whether live bacteria is required for triggering the
NCR1-mediated TNF-a secretion we repeated the in vivo chamber
model experiments with heat-treated F. nucleatum. As seen in
Figure 6A, 2 hours after inoculation with heat-killed F. nucleatum,
the percentages of NK cells in the chambers were similar to those
observed with the untreated, viable F. nucleatum (compare Figures 2
and 6). In contrast, 24 hours post inoculation, the percentages of
Figure 2. Infiltration of cells into challenged chambers. Immune cells in the chambers were analyzed by FACS 2 hours (A) and 24 hours (B)
following bacteria inoculation. The intrinsic GFP labeling marks mainly NK cells. Staining was performed with Phycoerythrin conjugated anti-DX5 and
anti-NKG2D mAbs. Staining with NK1.1 was visualized by using Cy-5 conjugated strepavidin. The cell percentage and cell numbers is indicated in
each quadrant. One representative experiment out of four is shown.
doi:10.1371/journal.ppat.1002601.g002
Figure 3. Survival of bacteria in chamber exudates. Viable CFU
from chamber exudates were determined, 2 h and 24 h following
inoculation of P. gingivalis, F. nucleatum or E. coli. Each symbol represents
anindividualmouse.Onerepresentativeexperimentoutoffourisshown.
The y axis represents number of colonies (logarithmic scale).
doi:10.1371/journal.ppat.1002601.g003
Direct Recognition of F. nucleatum by NCR1
PLoS Pathogens | www.plospathogens.org 4 March 2012 | Volume 8 | Issue 3 | e1002601NK cells in the chambers inoculated with the heat-killed F.
nucleatum were not elevated (as observed with the untreated F.
nucleatum, Figure 2), but rather stayed constant (Figure 6A).
We next tested whether the TNF-a production will be affected
by heat treatment. As can be seen in Figure 6B, a significant
secretion of TNF-a was still detected following the inoculation of a
heat-killed F. nucleatum bacteria (compared with the KO mice),
however this TNF-a secretion was significantly less pronounced as
compared with the F. nucleatum live bacteria. Thus, we concluded
that heat treatment of the bacteria affects NK cell accumulation in
the chamber and that it also slightly affects the NCR1-dependent
TNFa secretion.
To test whether the mouse NCR1 and the human NKp46
directly interact with F. nucleatum we used fusion proteins
(generated as previously described [17]), in which the extracellular
domains of NCR1 and of NKp46 are fused to the Fc portion of
human IgG1. As a negative control we used an Ig fusion protein
made of the membrane proximal domain of NKp46 (named D1),
that does not include the NKp46 site required for its binding
[17,21,43]. Importantly, as can be seen in Figure 7A, a specific,
dose dependent, binding of NCR1-Ig and NKp46-Ig was observed
to F. nucleatum, whereas little or no binding was observed to P.
gingivalis (Figure 7B).
We have previously showed that NKp46 and NCR1 recognize
influenza virus hemagglutinins [17,21,43]. To compare the
efficiency of the interactions of NKp46 and NCR1 with F.
nucleatum to that of hemagglutinin, we infected 721.221 cells with
the PR8 influenza virus. As can be seen in Figure 7C, in the
absence of infection little or no binding was observed when either
NKp46-Ig or NCR1-Ig were used. In agreement with previous
reports [17,21,43], following influenza infection, the binding of
NKp46-Ig and NCR1-Ig was substantially increased (Figure 7D).
The increased binding was dose-dependent (Figure 7) and was
noticed with similar concentrations of fusion proteins that were
used to detect binding to F. nucleatum.
For unknown reasons the P. gingivalis staining is sometimes
observed as a smeared peak (Figure 7B) and sometimes appeared
as a single peak (Figure 7E). Thus, to further demonstrate that the
F. nucleatum recognition by NKp46/NCR1 is specific and that P.
gingivalis is indeed not recognized by NKp46/NCR1 we stained
the P. gingivalis and the F. nucleatum bacteria with various killer
receptors fused to Ig. As can be seen in Figure 7E little or no
staining of the Ig-fusion proteins (NKp46D1-Ig, NCR1-Ig,
NKp46-Ig, NKG2D-Ig, NKp44-Ig, NKp30-Ig and CD16-Ig)
was observed with the P. gingivalis, whereas F. nucleatum was
recognized only by the human NKp46-Ig and its mouse
orthologue NCR1-Ig (Figure 7E).
Binding of NCR1 and NKp46 to F. nucleatum is heat,
proteinase K and pronase sensitive
We have previously shown that the recognition of influenza
hemagglutinin by NCR1 and by NKp46 requires the sialylation of
these receptors and that it is sensitive to digestion with neuroami-
nidase (NA) [17,21,43].Wethereforetestedwhether bindingNCR1
and NKp46 to the unknown F. nucleatum ligand also involves sialic
acid residues. For this, we treated the proteins with bacterial
neuraminidase and observed that such treatment did not affect the
binding to F. nucleatum (data not shown), suggesting that binding of
NCR1 and NKp46 to the fusobacterial ligand is mechanistically
different from the binding to viral hemagglutinins.
To further delineate the nature of the fusobacterial ligand, we
tested the binding of NCR1-Ig and NKp46-Ig to heat-killed F.
nucleatum,o rt oF. nucleatum that was treated with enzymes
(proteinase K or pronase) known to modify proteins on bacterial
surfaces. Because the proteinase K or pronase enzymes are active
at 55uC we also tested whether NCR1-Ig and NKp46-Ig interact
with F. nucleatum after heating the bacteria at 55uC for 1 hour and
observed efficient binding (data not shown). Furthermore, as
shown in Supplementary Figure S1, all treatments did not affect
the integrity or the presence of the bacteria.
Figure 8 shows that the F. nucleatum ligand is either a protein or a
modification found on a protein, as heat, proteinase K and
pronase treatments significantly reduced the binding of both the
NCR1-Ig and the NKp46-Ig fusion proteins.
The direct interaction between F. nucleatum and NCR1 is
functional, resulting in TNF-a secretion
Next, we tested whether the direct interaction of F. nucleatum and
NCR1 is functional. For this purpose, we initially used a reporter
Figure 4. Cytokine profiles in challenged chambers. TNF-a levels were determined by ELISA in chamber exudates of Ncr1
+/+ (WT) and
Ncr1
gfp/gfp (KO) mice at baseline (0), 2 h and 24 h following bacterial challenge. Data represent absorbance at 650 nm 6 SD and are average of three
different experiments. ** p,0.01.
doi:10.1371/journal.ppat.1002601.g004
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chain and expressed this chimeric receptor in mouse BW cells.
Triggering of this chimeric receptor will lead to the secretion of
mouse IL-2, thus reporting for functional interaction of NCR1
with its ligand. However, upon generating this reporter system, a
substantial secretion of IL-2 was observed, even without the
addition of the bacteria (Figure 9A). A possible explanation to this
observation is that the mouse BW cells express an unknown tumor
ligand for the mouse NCR1 which consistently triggers IL-2
secretion as BW cells are specifically recognized by NCR1-Ig (data
not shown).
Because we demonstrated above that both the mouse NCR1
and the human NKp46 receptors directly interact with F.
nucleatum, we next examined whether we could use the human
NKp46 protein fused to zeta as our reporter system. Importantly,
as can be seen in Figure 9A, the self-secretion of IL-2 from the
BW-46 cells was much lower than that of BW-NCR1. Further-
more, the NKp46 reporter system was functional as triggering of
NKp46-zeta on BW cells by using plate bound anti-NKp46
resulted in a dose dependent IL-2 secretion (Figure 9B).
Therefore, BW-46-zeta transfectants were incubated with viable
F. nucleatum, with heat-killed F. nucleatum and with F. nucleatum
treated with proteinase K or with pronase. PR8 influenza virus
infected 721.221 cells were used as positive control (Figure 9C).
Incubations were performed for 48 hours in the presence, or in the
absence of anti-NKp46 mAb and IL-2 levels were measured in the
supernatants. Figure 9C reveals that F. nucleatum induced a
significant secretion of IL-2 from BW-NKp46 cells and this
secretion was almost completely blocked by the anti-NKp46 mAb.
Furthermore, (in agreement with the above binding results), heat-
killed bacteria, or bacteria treated with proteinase K or with
pronase induced little or no IL-2 secretion. The activation of this
Figure 5. The infiltration of immune cells into the F. nucleatum challenged chambers is NCR1-independent. The presence of immune
cells; (A) lymphocytes and (B) DC (identified by CD11c) and macrophages (identified by F4/80) in the chambers were analyzed by FACS, 2 hours
following the injection of F. nucleatum. The mAb used for staining is indicated in the Y axis. IC is isotype control. The percentage of the various cells
and the cell numbers are indicated in each quadrant. One representative experiment out of four is shown.
doi:10.1371/journal.ppat.1002601.g005
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as compared with F. nucleatum as incubation of the BW-NKp46
cells with infected 721.221 cells resulted in pronounced IL-2
secretion.
Our final effort was to demonstrate that the direct interaction
between NCR1 and F. nucleatum will lead to TNF-a secretion. For
this purpose we isolated (using the autoMACS instrument) mouse
NK cells from Ncr1
gfp/gfp and Ncr1
+/gfp mice, incubated them with
F. nucleatum or with P. gingivalis and tested the supernatants for the
presence of TNF-a. As shown in Figure 10, no TNF-a secretion
was observed when NK derived from the Ncr1
gfp/gfp mice were
incubated with F. nucleatum, while a significant secretion was
detected when the Ncr1
+/gfp mice were used. The TNF-a secretion
was F. nucleatum-specific since P. gingivalis had no effect (Figure 10).
Discussion
Periodontitis is a bacterial-induced inflammatory process that
leads to the destruction of the tooth-supporting tissues and to tooth
loss. It is one of the most common chronic inflammatory diseases
in humans [44] and has been suggested as a risk factor for variable
systemic conditions including rheumatoid arthritis, atherosclerosis
and preterm births [45–47].
Here we investigated whether NK cells are involved in
periodontitis through the interaction between their specific NK
receptor NKp46 with periodontal bacteria. We used two
complementary animal models. In the first model we induced
experimental periodontitis by orally infecting the Ncr1
+/+ and
Ncr1
gfp/gfp animals with periodontal pathogenic bacteria. We show
that in the absence of NCR1, when mice are infected with F.
nucleatum, no loss of alveolar bone around the teeth is observed,
while when mice were infected with P. gingivalis bone loss was
observed independent of NCR1.
Due to technical and ethical limitations additional experiments
could not be investigated in this model and we therefore used the
subcutaneous chamber model [40,41] to study the NKp46/NCR1
activity with regard to periodontal pathogens. Interestingly, we
noticed that a large fraction of immune cells present in the
inflamed chambers express NK cell markers such as NKG2D,
DX5 and NK1.1, however these cells were not NK (GFP2), or T
cells (CD32). The identity and the function of these cells will be
elucidated in future studies.
We show that in response to challenge with F. nucleatum and P.
gingivalis, NK cells accumulate in the inflamed chambers, that F.
nucleatum trigger the secretion of TNF-a and that the presence of
TNF-a in the chambers is NCR1-dependent.
The interactions of NK cells with the bacteria probably renders
them sensitive to in vitro manipulations and therefore we were not
able to directly demonstrate that, in the chambers, NK cells are
the main producers of TNF-a. Nevertheless, it is likely that TNF-a
is indeed secreted by NK cells, in vivo, in response to F. nucleatum
because upon incubation of isolated NK cells with F. nucleatum,a n
NCR1-dependent TNF-a secretion is observed.
Because alveolar bone loss is observed following P. gingivalis
infection and since TNF-a could hardly be detected in the
chambers following P. gingivalis infection we suggest that TNF-a
has little role in the induction of the P. gingivalis-mediated bone loss
in the system we used.
Figure 6. In vivo response to heat-treated F. nucleatum bacteria. (A) FACS analysis of chamber exudates, 2 hours and 24 hours following
challenge with heat-killed F. nucleatum. Staining was performed with Phycoerythrin conjugated anti-DX5 mAb. The percentages of GFP
+ NK cells are
indicated. One representative experiment out of three is shown. (B) TNF-a level in chamber exudates of Ncr1
+/+ (WT) and Ncr1
gfp/gfp (KO) was
determined by ELISA, 2 and 24 hours following challenge with viable and heat-killed F. nucleatum. Data represent absorbance at 650 nm 6 SD and
are average of two different experiments. * p,0.05, ** p,0.01.
doi:10.1371/journal.ppat.1002601.g006
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pleotropic effects on both the immune and the skeletal systems. Its
role and its contribution to the pathogenesis of chronic
periodontitis, tissue destruction and bone loss has been clearly
documented [48–50] and administration of anti-TNF-a antibodies
resulted in reduced alveolar bone loss [51–54].
Previous studies demonstrated that the direct recognition of
tumor cells [21,43], viral infected cells [17,43] and beta cells [20]
Figure 7. Direct binding of NCR1 and NKp46 to F. nucleatum. F. nucleatum (A), P. gingivalis (B), uninfected 721.221 cells (C), and 721.221 cells
infected with influenza PR8 virus (D), were stained with NCR1-Ig (left) and with NKp46-Ig (right) at two different dosages; 5 mg, blue line and 1 mg, red
line. Staining was visualized using a Phycoerythrin conjugated anti-human Ig antibody. The filled grey histograms represent control staining with the
NKp46D1-Ig fusion protein. The Median Fluorescence Intensity (MFI) values of the D1-Ig, NCR1-Ig and NKp46 staining are indicated in each of the
histograms. One representative experiment out of five is shown. (E) F. nucleatum (upper) and P. gingivalis (lower) bacteria were stained with various
activating NK cell receptors fused to Ig (indicated above the quadrants). Figure shows one representative experiment out of three performed.
doi:10.1371/journal.ppat.1002601.g007
Figure 8. The F. nucleatum ligand is sensitive to heat, proteinase K and pronase treatment. Viable untreated, or treated (treatments are
indicated above the histograms) F. nucleatum bacteria were stained with 5 mg of NCR1-Ig (upper) and of NKp46-Ig (lower). Filled grey histograms
represent the staining with the NKp46D1-Ig. The blue histograms represent the staining of the untreated F. nucleatum and the red histograms
represent the staining of the treated F. nucleatum. One representative experiment out of three is shown.
doi:10.1371/journal.ppat.1002601.g008
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and IFN-c [22,55–57]. In our experimental system TNF-a, but
not IFN-c was present in the chambers. Similar observations were
noted in other studies and it was proposed that NK cells shape
their functional phenotype depending on the nature of the stimuli.
For example, some tumors were able to induce TNF-a, but not
IFN-c secretion when co-cultured with naı ¨ve NK cells and only
when NK cells were activated with IL-2, a significant increase in
IFN-c could be seen [58]. Another study showed that IL-4
compromised the ability of stimulated NK cells to release IFN-c,
without affecting the secretion of TNF-a [15] and interestingly IL-
4 was detected in the chambers’ exudates (data not shown).
The TNF-a response to F. nucleatum was NCR1-dependant,
however, in the chamber experiments, in the absence of NCR1,
the TNF-a secretion was markedly reduced but not totally
abrogated. In contrast, no TNF-a secretion was observed from
purified NK cells lacking NCR1 that interacted with F. nucleatum.
This suggests that in the chambers, cells other than NK cells
probably provide additional source for TNF-a. Indeed, previous
studies showed that F. nucleatum-derived lipopolysaccharide up-
regulated the secretion of the TNF-a by macrophage-like cells
[59]. As shown here, macrophages and DCs are also present in the
F. nucleatum-inflamed chambers and therefore we can speculate
that the low level of TNF-a observed in the chambers implanted in
the NCR1
gfp/gfp animals is released either by macrophages
recruited into the chambers, or by other immune cells.
Twenty four hours following bacteria inoculation, the TNF-a
levels dramatically dropped to almost baseline levels, in spite of the
continuous accumulation of NK cells in the chambers. This
transient nature of TNF-a response has been reported previously
[60,61] and we assume that the TNF-a levels decline due to the
elimination of F. nucleatum (the stimulating antigen) from the
chambers during the study period.
In summary, we provide here the first evidence that NKp46 and
NCR1 directly recognize a periodontal pathogen and we show
that this recognition is heat, proteinase K and pronase sensitive,
suggesting that the bacterial ligand is a protein or modifications of
protein. Our data support the idea that periodontal pathogens
initiate the disease by activating host mechanisms that conse-
quently contribute to the destruction of the supporting apparatus
of the periodontium by releasing inflammatory mediators, such as
TNF-a.
Figure 9. Functional reporter assays. (A) Basal IL-2 secretion of BW-NCR1, BW-NKp46 and parental BW cells. (B) BW-NKp46 transfected cells were
cultured for 48 h in presence of plate bound (dosages indicated in the X axis) anti NKp46 mAb and control mAb. (C) 5610
4 BW-NKp46 transfected
cells were cultured for 48 hours, with treated or untreated F. nucleatum and with 721.221 cells infected with PR8 influenza virus in the presence and
in the absence of anti-NKp46 mAb. IL-2 secretion was determined by ELISA. Data represent absorbance at 650 nm 6 SD and are average of two
different experiments * p,0.05, ** p,0.01.
doi:10.1371/journal.ppat.1002601.g009
Figure 10. NCR1-dependent secretion of TNF-a following
interaction with F. nucleatum. NK cells isolated from Ncr1
+/gfp (Het)
and from Ncr1
gfp/gfp (KO) mice were cultured with F. nucleatum and with
P. gingivalis bacteria for 48 hours. TNF-a secretion was determined by
ELISA. Data represent absorbance at 650 nm 6 SD and are average of
two different experiments. *** p,0.001.
doi:10.1371/journal.ppat.1002601.g010
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Mice
The generation of the Ncr1
gfp/gfp knockout mice has been
previously described [21]. All experiments were performed in the
specific pathogen–free unit of Hadassah Medical School (Ein-
Kerem, Jerusalem) according to guidelines of the ethical
committee. Ethics statement: This study was carried out in strict
accordance with the Law for the Prevention of Cruelty to Animals
(1994) and the regulations of the Hebrew University of Jerusalem
Ethics Committee for Maintenance and Experimentation on
Laboratory Animals. The protocol was approved by the
Committee on the Ethics of Animal Experiments of the Hebrew
University of Jerusalem (Permit Number: 11-5413). All surgery
was performed under sodium pentobarbital anesthesia, and all
efforts were made to minimize suffering.
Bacterial strains and growth conditions
P. gingivalis strain ATCC3327 and F. nucleatum strain PK1594
were grown in an Bactron II anaerobic (N2:CO2:H2, 90:5:5)
chamber (Sheldon Manufacturing Inc., Cornelius, OR) at 37uCi n
Wilkins-Chalgran anaerobic broth (Fluka, Spain) anaerobic
chamber. E. coli strain ATCC25922 was grown in LB broth
(Lennox, BD, Maryland, USA). Bacterial purity was determined
by phase contrast microscopy. Bacteria were harvested during the
logarithmic phase, washed by centrifugation and resuspended in
phosphate-buffered saline (PBS) at 10
7 bacteria/ml [40,62]. Heat-
killing was performed at 100uC for 10 min.
Experimental periodontitis model
Infection was carried out as described by Baker at al. 2000 and
Wilensky et al. 2009 [63,64]. In brief, four to five-week-old Ncr1
+/
+ (WT) and Ncr1
gfp/gfp (KO) mice were given sulfamethoxazole/
trimethoprim 0.08% and 0.016% respectively, in drinking water,
ad libitum for 10 days. Three days following the withdrawal of
antibiotics (day 14), the animals were infected with F. nucleatum or
with P. gingivalis (2610
8 CFU in 0.2 ml of PBS and 2%
carboxymethylcellulose) or vehicle only. The infection was carried
out by gavage into the esophagus and oral cavity 3 times, once
every other day. Forty two days after the last infection, the mice
were sacrificed and the hemi-maxillae were collected and prepared
for bone loss measurements using the micro computerized-
tomography (mCT) technique [38]. At the end of the experiments
mice were killed by CO2.
Quantification of alveolar bone loss
For quantitative 3-dimensional analysis of the alveolar bone
loss, the hemi-maxillae were examined by a desktop micro-CT
system (mCT 40, Scanco Medical AG, Bassersdorf, Switzerland).
The sagittal plan of the specimens was set parallel to the X-ray
beam axis. The specimens were scanned at a resolution of 12 mm
in all 3 spatial dimensions. The scans were Gaussian-filtered and
segmented using a multi-level global thresholding procedure for
the segmentation of enamel, dentin and bone. Residual supportive
bone volume (RSBV) was determined separately for either root
(bucco-mesial and bucco-distal) using a direct 3-dimensional
approach [65]. The measured mesio-distal length of the alveolar
bone was 204 mm and 120 mm for the mesio-buccal and the disto-
buccal roots, respectively. The apical basis of the measured
volume was set mesio-distally parallel to the cemento-enamel
junction (CEJ) and bucco-palatinally parallel to the occlusal plane.
The results represented the residual bone above the reference
plane in mm
3 [38].
Subcutaneous chamber model
Two titanium coil chambers were inserted subcutaneously into
anesthetized 6–8 week-old male mice as previously described [41].
After 10–14 days, the chambers were thoroughly emptied of their
exudates and P. gingivalis, F. nucleatum and E. coli (10
6 bacteria in
100 ml of PBS) were immediately injected into each chamber. The
exudates were collected at 2 and 24 h post-infection (each
chamber was sampled only once). After centrifugation at
4000 rpm for 20 min, the supernatants were collected for bacterial
counts and cytokine analysis. To remove red blood cells the pellets
were re-suspended in 3 ml of cold lysis buffer containing NH4Cl
(1.55M), KHCO3 (0.138M) and NaEDTA (0.684 mM) at pH 7.3
for 3 min, after which the cells were washed and re-suspended in
0.5% BSA/PBS for flow cytometry analysis.
Flow cytometry
Antibodies specific for NK cells (DX5; Caltag Laboratories,
Burlingame, CA, USA), NKG2D (CX5; eBioscience, San Diego,
CA, USA) were conjugated to phycoerythrin. DC were identified
by CD11c (eBioscience, San Diego, CA, USA), macrophage with
F4/80 (eBioscience, San Diego, CA, USA) and T cells were
stained with CD3, CD4 and CD8 (BD Pharmingen, San Diego,
CA, USA). NK1.1 antibody was produced in PK136 hybridoma
cell line, as previously described [66]. Staining of NK1.1 was
visualized with a secondary Cy5-conjugated strepavidin (Jackson
ImmunoResearch Laboratories, West Grove, PA, USA). For
intracellular staining cells were washed with Perm Wash (BD
Pharmingen, San Diego, CA, USA), fixed and treated with
Brefeldin A (Cell Signaling Technology) for 5 hours at 37uC. Cells
were then incubated with antibodies to TNF-a (BD Pharmingen,
San Diego, CA, USA).
Cytokine analysis
The levels of TNF-a in chamber exudates were determined by
ELISA as previously described [67].
Determining the presence of viable bacteria in the
chambers
Ten microliters of chamber exudates was serially diluted in
duplicates in PBS and plated on tryptic soy agar containing sheep
blood (Hylabs, Rehovot, IL). Plates with exudates from chambers
challenged with P. gingivalis and F. nucleatum were grown under
anaerobic conditions for 5–7 days at 37uC, while plates with
exudates from E. coli challenged mice were grown in aerobic
conditions at 37uC for 24 hours. The bacteria in the different
colonies were identified by phase contrast microscopy. In addition,
P. gingivalis colonies were confirmed by their black pigment.
Staining of bacteria with soluble fusion proteins
The generation of NCR1-Ig, NKp46-Ig, NKp46D1-Ig, NKp44,
NKG2D, NKp30 and CD16 was previously described [17,18].
Proteins were purified on protein A/G columns as previously
described [17,18]. 2610
5 bacteria were stained with 5 mg fusion
proteins (unless indicated otherwise). Staining was performed in
the absence of azid and was visualized using a Phycoerythrin or
Allophycocyanin conjugated anti-human Ig antibody.
Interleukin-2 (IL-2) release assays from mouse lymphoma
BW cells transfectants
Generation of the stable transfectants BW-NCR1 and BW-
NKp46 was previously described [17]. 10
5 treated and untreated
F. nucleatum and 5610
4 influenza PR8-infected or uninfected
721.221 cells were incubated with 5610
4 BW-NKp46 cells in the
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(generated in our laboratory). All assays were performed in
medium that do not contain antibiotics, at 37uC for 48 hours. The
presence of IL-2 was measured by ELISA kit (BD Pharmingen,
San Diego, CA, USA).
TNF-a release assays from freshly-isolated NK cells
NK cells were isolated from splenocytes obtained from Ncr1
+/gfp
and from the Ncr1
gfp/gfp mice by using an NK isolation kit
(Miltenyi Biotech, Auburn, CA).The percentage of GFP
+ cells was
assessed by FACS and 5610
4 NK cells were cultured with 10
5 F.
nucleatum and P. gingivalis bacteria for 48 hours at 37uC. The
presence of TNF-a was determined by ELISA.
Supporting Information
Figure S1 F. nucleatum remain intact following heat,
protease K, and pronase treatment. Phase microscopy
(61,000 magnification) and q-PCR quantification of treated and
untreated bacteria.
(TIF)
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